In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Cell and gene therapies require novel quality control methods due to their complex, variable nature and limited shelf life, challenging traditional pharmaceutical testing approaches. Manufacturers ...

The ambitious task on hand is apparent from the weighty title of the report – ‘Landscape Analysis on Alternatives to Animal Testing for Drug Development in India.’ That the report has the foreword by ...

Dr Reddy’s, Humane World for Animals India and DBT BRiC – Institute for Stem Cell Science and Regenerative Medicine (InStem) is accelerating India’s drug development and improving patient outcomes ...

For decades, traditional animal testing has been the gold standard for evaluating drug safety, but a growing body of evidence suggests that these methods may not always provide the most accurate ...

At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...